The Internationalization of Compound Artemisinin and Its Enlightenment
The development of artemisinin-based combination therapies (ACTs) was inspired by traditional Chinese medicine and developed through modern pharmaceutical technologies to achieve innovative breakthroughs in antimalarial drug development. Its international certification and promotion played an important role in malaria prevention and control, building a global community of health for all. Despite its proven efficacy in malaria treatment, its entry into the international market and participation in anti-malaria aid was not a smooth path. The internationalization of ACTs has undergone three stages: using "translation" to promote international certification of Coartem, recruiting actors to accelerate the independent research and development of antimalarial drugs, and practicing greater good and shared interests to expand the global presence of artemisinin therapies. The process not only transformed ACTs from a domestically developed drug into an internationally recognized antimalarial drug, but also provided valuable enlightenment for the global entry of other new drugs developed in China.
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nanjing University (CN)
Publication Details
- Journal
- SHILAP Revista de lepidopterología
- Published
- 2025-06-01
- DOI
- https://doi.org/10.12014/j.issn.1002-0772.2025.11.13
- Primary Topic
- Canadian Policy and Governance
- Type
- article
- Field-Weighted Citation Impact
- 0.00